It has been reported that knock-down of c-Met by siRNA and inhibitor treatment results in decrease of ALDH1A3 gene expression and ALDEFLUOR activity in pancreatic cancer cell lines with high levels of c-Met [25]. This evidence concerns the gene ALDH1A3 and pancreatic neoplasm.